Yuji Oshima

4.7k total citations · 1 hit paper
91 papers, 3.8k citations indexed

About

Yuji Oshima is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Yuji Oshima has authored 91 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Ophthalmology, 29 papers in Radiology, Nuclear Medicine and Imaging and 27 papers in Molecular Biology. Recurrent topics in Yuji Oshima's work include Retinal Diseases and Treatments (43 papers), Glaucoma and retinal disorders (18 papers) and Retinal Imaging and Analysis (14 papers). Yuji Oshima is often cited by papers focused on Retinal Diseases and Treatments (43 papers), Glaucoma and retinal disorders (18 papers) and Retinal Imaging and Analysis (14 papers). Yuji Oshima collaborates with scholars based in Japan, United States and Switzerland. Yuji Oshima's co-authors include Tatsuro Ishibashi, Peter A. Campochiaro, Taiji Sakamoto, Sean F. Hackett, Koh‐Hei Sonoda, Shigeo Yoshida, Takeru Yoshimura, Yasuaki Hata, Hiroyuki Nambu and Tatsuro Ishibashi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Environmental Science & Technology.

In The Last Decade

Yuji Oshima

86 papers receiving 3.7k citations

Hit Papers

Cell Type–Specific Regula... 2003 2026 2010 2018 2003 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yuji Oshima 2.0k 1.6k 1.3k 449 408 91 3.8k
Richard M. Rohan 1.3k 0.6× 2.3k 1.5× 1000 0.8× 477 1.1× 595 1.5× 56 4.7k
Sean F. Hackett 1.5k 0.7× 2.1k 1.3× 832 0.6× 692 1.5× 190 0.5× 54 3.2k
Ingeborg Klaassen 1.2k 0.6× 1.5k 0.9× 706 0.5× 360 0.8× 220 0.5× 71 3.0k
Imran Ahmed Bhutto 3.3k 1.6× 2.3k 1.5× 1.9k 1.5× 183 0.4× 304 0.7× 97 4.8k
Miyo Matsumura 2.7k 1.3× 1.6k 1.0× 1.6k 1.2× 210 0.5× 175 0.4× 138 4.1k
Andreas Stahl 2.6k 1.2× 1.9k 1.2× 2.4k 1.9× 390 0.9× 388 1.0× 144 5.4k
Yasuaki Hata 2.5k 1.2× 1.4k 0.9× 2.0k 1.5× 217 0.5× 182 0.4× 62 3.7k
Stanley A. Vinores 2.6k 1.3× 2.0k 1.3× 1.4k 1.0× 279 0.6× 199 0.5× 97 4.5k
Keijiro Ishikawa 1.3k 0.6× 964 0.6× 716 0.5× 207 0.5× 344 0.8× 91 2.2k
Nancy C. Joyce 1.2k 0.6× 1.3k 0.8× 3.2k 2.5× 141 0.3× 224 0.5× 64 4.5k

Countries citing papers authored by Yuji Oshima

Since Specialization
Citations

This map shows the geographic impact of Yuji Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Oshima more than expected).

Fields of papers citing papers by Yuji Oshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Oshima. The network helps show where Yuji Oshima may publish in the future.

Co-authorship network of co-authors of Yuji Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Oshima. A scholar is included among the top collaborators of Yuji Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Oshima. Yuji Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Iori, Yuji Oshima, Yosuke Fukuda, et al.. (2025). Five-year Outcome of Aflibercept Administration with “Treat and Extend” for Neovascular Age-Related Macular Degeneration. Clinical ophthalmology. Volume 19. 835–845. 1 indexed citations
2.
Oshima, Yuji, Naoyasu Umeda, Shigeo Yoshida, et al.. (2021). Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study. BMC Ophthalmology. 21(1). 58–58. 7 indexed citations
3.
Nagai, Yoshimi, Ryusaburo Mori, Koji Tanaka, et al.. (2020). <p>Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment</p>. Patient Preference and Adherence. Volume 14. 553–567. 22 indexed citations
4.
Oshima, Yuji, Kenichi Kimoto, Noriko Yoshida, et al.. (2017). One-Year Outcomes following Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in Japanese Patients: The APOLLO Study. Ophthalmologica. 238(3). 163–171. 1 indexed citations
5.
Obata, Ryo, Yasuo Yanagi, Tatsuya Inoue, et al.. (2017). Prevalence and factors associated with age-related macular degeneration in a southwestern island population of Japan: the Kumejima Study. British Journal of Ophthalmology. 102(8). 1047–1053. 8 indexed citations
6.
Kato, Aki, Ari Shinojima, Miki Sawa, et al.. (2015). A Multicenter Randomized Controlled Study of Antioxidant Supplementation with Lutein for the Treatment of Chronic Central Serous Chorioretinopathy. Investigative Ophthalmology & Visual Science. 56(7). 167–167. 1 indexed citations
7.
Kobayashi, Yoshiyuki, Shigeo Yoshida, Yedi Zhou, et al.. (2015). The role of tenascin-C in fibrovascular membrane formation in diabetic retinopathy. Investigative Ophthalmology & Visual Science. 56(7). 224–224. 1 indexed citations
8.
Takeda, Atsunobu, Eiichi Hasegawa, Hisakata Yamada, et al.. (2014). EBI3 is pivotal for the initiation of experimental autoimmune uveitis. Experimental Eye Research. 125. 107–113. 10 indexed citations
9.
Yamaguchi, Muneo, Shintaro Nakao, Yuji Oshima, et al.. (2014). Impact of Anti-VEGF Therapy on the Photoreceptor Layer in Age-related Macular Degeneration: Short-term Evaluation Using Adaptive Optics Scanning Laser Ophthalmoscopy. Investigative Ophthalmology & Visual Science. 55(13). 2609–2609.
10.
Oshima, Yuji, Shinnosuke Takamichi, Tomoki Toda, et al.. (2014). Prosody Correction Preserving Speaker Individuality in English-Read-By-Japanese Speech Synthesis Based on HMM. IEICE technical report. Speech. 114(365). 63–68. 1 indexed citations
11.
Sassa, Yukio, Shigeo Yoshida, Keijiro Ishikawa, et al.. (2013). The significant relationships between Fibronectin, Tenascin-C and Periostin in the eyes of the patients with diabetic retinopathy. Investigative Ophthalmology & Visual Science. 54(15). 1160–1160. 1 indexed citations
12.
Asato, Ryo, Shigeo Yoshida, Atsushi Ogura, et al.. (2013). Comparison of Gene Expression Profile of Epiretinal Membranes Obtained from Eyes with Proliferative Vitreoretinopathy to That of Secondary Epiretinal Membranes. PLoS ONE. 8(1). e54191–e54191. 32 indexed citations
13.
Yasuda, Miho, Yuji Oshima, Sawako Hashimoto, et al.. (2011). Prevalence and Systemic Relevant Factors of Polypoidal Choroidal Vasculopathy in a General Japanese Population: The Hisayama Study. Investigative Ophthalmology & Visual Science. 52(14). 97–97. 1 indexed citations
14.
Oshima, Yuji, et al.. (2010). Three-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients. Investigative Ophthalmology & Visual Science. 51(13). 74–74.
15.
Oshima, Yuji, Sachiko M. Oshima, Kentaro Takahashi, et al.. (2003). Angiopoietin 2 (Ang2) Increases or Decreases Neovascularization (NV) Depending Upon the Setting. Investigative Ophthalmology & Visual Science. 44(13). 4519–4519. 3 indexed citations
16.
Zhang, Rong, et al.. (2003). Effect of Acute L-Tryptophan Exposure on the Brain Serotonergic System and Behavior in the Male Medaka. ZOOLOGICAL SCIENCE. 20(2). 121–124. 11 indexed citations
17.
Hisatomi, Toshio, Taiji Sakamoto, Yoshinobu Goto, et al.. (2002). Critical role of photoreceptor apoptosis in functional damage after retinal detachment. Current Eye Research. 24(3). 161–172. 125 indexed citations
18.
Oshima, Yuji, et al.. (2002). Gene transfer of soluble TGF-β type II receptor inhibits experimental proliferative vitreoretinopathy. Gene Therapy. 9(18). 1214–1220. 28 indexed citations
19.
Hisatomi, Toshio, Taiji Sakamoto, Toshinori Murata, et al.. (2001). Relocalization of Apoptosis-Inducing Factor in Photoreceptor Apoptosis Induced by Retinal Detachment in Vivo. American Journal Of Pathology. 158(4). 1271–1278. 146 indexed citations
20.
Sakamoto, Taiji, Yuji Oshima, Tatsuro Ishibashi, et al.. (1999). The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy. Current Eye Research. 19(4). 323–329. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026